Home Nav
Nextech Invest Logo

William G. Kaelin

Alfred Scheidegger

William G. Kaelin MD is a professor in the Department of Medicine at the Dana-Farber Cancer Institute, Harvard Medical School, and associate director, Basic Science, for the Dana-Farber/Harvard Cancer Center. He is a member of the board of scientific advisors of the National Cancer Institute, USA, of the National Cancer Policy Board, Institute of Medicine, USA. Dr Kaelin serves as member of the board of directors of Eli Lilly and Company and the American Association for Cancer Research. He is involved with advisory provision to several oncology companies.

 

17th Annual Biotech in Europe Forum

26.09. – 27.09.2017

Basel

  • 10.09.2017

    Blueprint Medicines announces new data from ongoing...

  • 07.09.2017

    TRACON Pharmaceuticals announces completion of enrollment...

  • 07.09.2017

    Kura Oncology announces positive Phase II study for...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close